stoxline Quote Chart Rank Option Currency Glossary
  
Alpha Teknova, Inc. (TKNO)
8.28  0.08 (0.98%)    02-14 16:00
Open: 8.1
High: 8.7999
Volume: 152,354
  
Pre. Close: 8.2
Low: 8.09
Market Cap: 441(M)
Technical analysis
2025-02-14 4:51:54 PM
Short term     
Mid term     
Targets 6-month :  10.67 1-year :  12.11
Resists First :  9.13 Second :  10.36
Pivot price 9.01
Supports First :  7.15 Second :  5.94
MAs MA(5) :  8.46 MA(20) :  8.82
MA(100) :  7.33 MA(250) :  4.57
MACD MACD :  0 Signal :  0.1
%K %D K(14,3) :  14.4 D(3) :  22.6
RSI RSI(14): 46
52-week High :  10.36 Low :  1.15
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ TKNO ] has closed above bottom band by 13.4%. Bollinger Bands are 5.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 8.81 - 8.84 8.84 - 8.88
Low: 8 - 8.04 8.04 - 8.08
Close: 8.22 - 8.27 8.27 - 8.34
Company Description

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

Headline News

Mon, 17 Feb 2025
Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World

Sun, 16 Feb 2025
60,000 Shares in Alpha Teknova, Inc. (NASDAQ:TKNO) Purchased by Nkcfo LLC - MarketBeat

Fri, 14 Feb 2025
Alpha Teknova (NASDAQ:TKNO) Shares Gap Up - Time to Buy? - MarketBeat

Thu, 13 Feb 2025
Alpha Teknova (NASDAQ:TKNO) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat

Wed, 12 Feb 2025
Here’s What Boosted Alpha Teknova (TKNO) in Q4 - Yahoo Finance

Tue, 11 Feb 2025
Craig-Hallum initiates Alpha Teknova stock with buy rating - MSN

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 53 (M)
Shares Float 8 (M)
Held by Insiders 9.3 (%)
Held by Institutions 80.6 (%)
Shares Short 645 (K)
Shares Short P.Month 295 (K)
Stock Financials
EPS -0.73
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.67
Profit Margin -87.2 %
Operating Margin -77.7 %
Return on Assets (ttm) -14 %
Return on Equity (ttm) -34 %
Qtrly Rev. Growth 17.2 %
Gross Profit (p.s.) 0.12
Sales Per Share 0.68
EBITDA (p.s.) -0.43
Qtrly Earnings Growth 0 %
Operating Cash Flow -14 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -11.5
PEG Ratio 0
Price to Book value 4.92
Price to Sales 12.14
Price to Cash Flow -30.77
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android